1) WHOLE BODY CHECKUP 1.0 105 Tests
VITAMIN- B12
THYROID PROFILE
PHOSPHORUS
LIVER FUNCTION TEST
LIPID PROFILE EXTENDED (MAXI HEART RISK PROFILE)
KIDNEY FUNCTION TEST (KFT) EXTENDED
IRON STUDY
ERYTHROCYTE SEDIMENTATION RATE (ESR)
COMPLETE URINE EXAMINATION
COMPLETE BLOOD COUNT (CBC)
CALCIUM PROFILE
BLOOD GLUCOSE
VITAMIN- D (25 HYDROXY)
IRON PROFILE
HBA1C
PERIPHERAL SMEAR
VITAMIN- B12
THYROID PROFILE
PHOSPHORUS
LIVER FUNCTION TEST
LIPID PROFILE EXTENDED (MAXI HEART RISK PROFILE)
KIDNEY FUNCTION TEST (KFT) EXTENDED
IRON STUDY
ERYTHROCYTE SEDIMENTATION RATE (ESR)
COMPLETE URINE EXAMINATION
COMPLETE BLOOD COUNT (CBC)
CALCIUM PROFILE
BLOOD GLUCOSE
VITAMIN- D (25 HYDROXY)
IRON PROFILE
HBA1C
PERIPHERAL SMEAR
1) Health Package Basic
CBC
LFT
KFT
LIPIDS
SUGAR FASTING
TSH
URINE ROUTINE
CBC
LFT
KFT
LIPIDS
SUGAR FASTING
TSH
URINE ROUTINE
TOTAL CHOLESTEROL.
TRIGLYCERIDES
HDL CHOLESTEROL.
LOw DENSTTY LIPOPROTEIN-CHOLESTEROL.
(LDL) VLDL TOTAL CHOLESTEROU/HDL RATO
LDL/HDL RATIO
NON HDL CHOLESTEROL
TRIGLYCERIDES
HDL CHOLESTEROL.
LOw DENSTTY LIPOPROTEIN-CHOLESTEROL.
(LDL) VLDL TOTAL CHOLESTEROU/HDL RATO
LDL/HDL RATIO
NON HDL CHOLESTEROL
BLOOD UREA
BLOOD UREA NITROGEN (BUN )
CREATININE
URICACID
BUN CREATININE RATIO
EGFR
BLOOD UREA NITROGEN (BUN )
CREATININE
URICACID
BUN CREATININE RATIO
EGFR
BLOOD UREA
BLOOD UREA NITROGEN (BUN )
CREATININE
URICACID
BUN CREATININE RATIO
EGFR
Sodium
Potassium
chloride
BLOOD UREA NITROGEN (BUN )
CREATININE
URICACID
BUN CREATININE RATIO
EGFR
Sodium
Potassium
chloride
BIIRUBIN TOTAL BILIRURIN DIREeT BIIRUBIN INDIRECT SGOT/AST SGPT/ALT ALKALINE PHASPHATASE (ALP) PROTEIN TOTAL SERUM ALBUMIN SERUM GLOBULIN ALBUMIN/GLOBULINRATIO GGT
HEMOGLOBIN (HBXWHOLE BLOOD EDTA) RED BLOOD CELLS PCV (HEMATOCRIT) MCV(MEAN CORPUSCULAR VOLUME) MCH (MEAN CORPUISCULAR Hn) MCHC (MEAN CORPUSCULAR Hn CONCENTRATION) RED CELLDISTRItTION W1om CV RED CELL DISTRIBUTION W1DTHSD WBC-TOTAL LEUCOCYTES COUNT NEUTROPILS LYMIPnoCYTES MoNOCYTES EosINorns BasoraS NEUTROPIILS (ARS) LYMPBOCYTES (AnS) MONOCYTES (ABS) EoSINOPunLS (ABS) BASOPHLS (ABS) PLATELETCOUNT MPY PDW PLATELETCRIT PLCR
Consultant Form Required with history
Crucial reproductive hormone produced by the anterior pituitary gland, regulated by the hypothalamus.
Female Reproductive Cycle: LH triggers the "LH surge" roughly 24–48 hours before ovulation, releasing a mature egg from the ovary. It also promotes the formation of the corpus luteum, which produces progesterone to prepare for potential pregnancy.
Female Reproductive Cycle: LH triggers the "LH surge" roughly 24–48 hours before ovulation, releasing a mature egg from the ovary. It also promotes the formation of the corpus luteum, which produces progesterone to prepare for potential pregnancy.
A sensitive cfDNA based screening test done for most common fetal aneuploidy disorders trisomy 13 (Patau Syndrome), trisomy 18 (Edward Syndrome), trisomy 21 [Down syndrome], Turner syndrome and sex chromosome aneuploidies [XXX, XXY, XYY]).
When should you consider this test?
The test can be done anytime after 10 week pregnancy.
When should you consider this test?
The test can be done anytime after 10 week pregnancy.
During your second trimester, your healthcare professional will ask you if you want the quad marker screen. If you choose to have the screening, you will be between weeks 15 and 20, counting from the first day of your last period, when you decide to do so. The 16th and 18th weeks are when you'll get the most accurate results.
The triple marker test is generally conducted between 15-20 weeks of pregnancy to optimize timing and accuracy. The ideal timing of a triple marker test in pregnancy is usually around 16-18 weeks gestation, which allows hormone levels to be measured most precisely. Too early, before 15 weeks, can increase false positive results. The test must be completed by 20 weeks to leave time for any follow-up diagnostic testing like amniocentesis if chromosomal abnormalities are suspected. When conducted during the optimal 15 to 20-week window, the triple marker test can provide the most accurate and actionable results to guide prenatal care.
The double marker test is usually performed between the 8th and 14th weeks of pregnancy as part of a full-fledged screening panel. The blood sample for this test is collected between the 11th and 13th week, which is the ideal time for combined risk assessment.
Doctors recommend this test for women above 35 years of age or those with birth defects in their family history as they are more likely to develop chromosomal abnormalities, which may lead to chromosomal malformations in the fetus.
Doctors recommend this test for women above 35 years of age or those with birth defects in their family history as they are more likely to develop chromosomal abnormalities, which may lead to chromosomal malformations in the fetus.
Sodium
Potassium
chloride
Potassium
chloride
Required for fasting sample 10 - 12 Hrs Fasting.
For PP sampel requested 2 Hrs After eat or Glucose. (As per procrastination)
Fit Random Any time.
For PP sampel requested 2 Hrs After eat or Glucose. (As per procrastination)
Fit Random Any time.
Grow your brand with Setmore